Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma
Jingshu Xiao, Jiaming Liang, Junjie Fan, et al.
Cancer Research (2022) Vol. 82, Iss. 18, pp. 3359-3374
Open Access | Times Cited: 17

Showing 17 citing articles:

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 64
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
Yi-Ying Wu, Te-Kai Sun, Ming‐Shan Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 34
Personalized Treatment of Glioblastoma: Current State and Future Perspective
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1579-1579
Open Access | Times Cited: 27
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
Xiaopeng Guo, Yixin Shi, Delin Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 21
Immunomodulatory effects of CDK4/6 inhibitors
Shumeng Zhang, Qiaomai Xu, Wenjia Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188912-188912
Closed Access | Times Cited: 16
Oncolytic virus therapy for malignant gliomas: entering the new era
Hirotaka Fudaba, Hiroaki Wakimoto
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 3, pp. 269-282
Closed Access | Times Cited: 12
Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma
Jiayu Zhang, Jinneng Yang, Jinyan Luo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tuning Cellular Metabolism for Cancer Virotherapy
Dian Xiong, Qing Wang, Weiming Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216924-216924
Closed Access | Times Cited: 2
Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis
Chudi Zhang, Jiang Li-hong, Xue Zhou, et al.
Translational Oncology (2023) Vol. 39, pp. 101812-101812
Open Access | Times Cited: 4
METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4
Xuesong Zhong, Sixue Wang, Xiaoli Yang, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 7, pp. 1145-1163
Open Access | Times Cited: 1
Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies
Trang Nguyen, Lloyd A. Greene, Hayk Mnatsakanyan, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1376-1376
Open Access | Times Cited: 1
A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition
Yan Wang, Youbin Li, Dong Liu, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5047-5047
Open Access | Times Cited: 3
DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
Nanbin Liu, Hailong Zhang, Chunli Zhang, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5228-5228
Open Access | Times Cited: 3
Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancer
Dorian V. Ziegler, Kanishka Parashar, Lluís Fajas
Seminars in Cancer Biology (2023) Vol. 98, pp. 51-63
Open Access | Times Cited: 3
Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives
Yongqin Liu, Yujiao Deng, Chang Yang, et al.
Bioengineering (2024) Vol. 11, Iss. 11, pp. 1084-1084
Open Access
SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation
Danmei Yan, Guannan Li, Yuan Yuan, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 3, pp. 397-409
Closed Access | Times Cited: 1
Page 1

Scroll to top